David P. Southwell, Director at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 77,536 shares at $15.19 ($1.2M) on 2018-12-13, disclosed to the SEC on 2018-12-14.
Open-market sale of $1.2M RCKT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.19 | 38,768 | $589K | 50.0% |
| 2 | $15.19 | 38,768 | $589K | 50.0% |
| Total | $15.19 avg | 77,536 | $1.2M | 100% |
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |